help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on October 6, 2009
Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2009-1231
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
94/11/4284    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Balsells, M.
Right arrow Articles by Corcoy, R.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Balsells, M.
Right arrow Articles by Corcoy, R.
Related Collections
Right arrow Pediatric Endocrinology
Right arrow Diabetes and Insulin
Right arrow Female Endocrinology

Submitted on June 23, 2009
Accepted on July 30, 2009

Maternal and Fetal Outcome in Women with Type 2 Versus Type 1 Diabetes Mellitus: A Systematic Review and Metaanalysis

Montserrat Balsells*, A. García-Patterson, I. Gich, and R. Corcoy

Servei d'Endocrinologia i Nutrició (M.B.), Hospital Mútua de Terrassa, Terrassa 08221, Spain; Servei d'Endocrinologia i Nutrició (A.G.-P., R.C.) y Servei d'Epidemiologia Clínica (I.G.), Hospital de la Santa Creu i Sant Pau, Barcelona 08025, Spain; and Centro de Investigación Biomédica en Red (CIBER) Bioengineering (R.C.), Biomaterials and Nanotechnology, Instituto de Salud Carlos III, Madrid 28029, Spain

* To whom correspondence should be addressed. E-mail: 23591mbc{at}comb.cat; endocrinologia@mutuaterrassa.es.

Context: Glycemic disturbance is usually less severe in pregnant women with type 2 than in those with type 1 diabetes mellitus (DM). Nevertheless, a worse perinatal outcome in women with type 2 DM has been reported in some studies.

Objective: Our objective was to review maternal and fetal outcomes in pregnant women with type 2 vs. type 1 DM.

Study Selection: We conducted a systematic review of papers providing original data on pregnancy outcomes in both type 2 and type 1 DM (Medline search of the period January 1, 1987, to June 30, 2008). Two independent investigators considered papers for eligibility, and a third one solved discrepancies.

Data Extraction: Metaanalysis tools were used to compare four main outcomes (major congenital malformations, stillbirth, and neonatal and perinatal mortality) and 15 secondary ones (five maternal, 10 fetal). Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines were used to assess quality.

Data Synthesis: Thirty-three studies qualified for inclusion of 3743 citations retrieved. Women with type 2 DM had lower glycated hemoglobin (HbA1c) at booking and throughout pregnancy but a higher risk of perinatal mortality [odds ratio (OR) 1.50, 95% confidence interval (CI) 1.15–1.96] without significant differences in the rates of major congenital malformations, stillbirth, and neonatal mortality. As to secondary outcomes, women with type 2 DM had less diabetic ketoacidosis (OR 0.09, 95% CI 0.02–0.34) and cesarean section (OR 0.80, 95% CI 0.59–0.94) without differences in other outcomes.

Conclusions: Despite a milder glycemic disturbance, women with type 2 DM had no better perinatal outcomes than those with type 1, indicating that type 2 DM in pregnancy is a serious condition.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society